Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
      • CryoStor CSB
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • ThawSTAR® Products
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality Management System
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
logo

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “RPE injury...

Tag: RPE injury model

Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs

Sharma, R., Khristov, V., Rising, A., Jha, B. S., Dejene, R., Hotaling, N., Li, Y., Stoddard, J., Stankewicz, C., Wan, Q., Zhang, C., Campos, M. M., Miyagishima, K. J., McGaughey, D., Villasmil, R., Mattapallil, M., Stanzel, B., Qian, H., Wong, W., Chase, L., Charles, S., McGill, T., Miller, S., Maminishkis, A., Amaral, J., Bharti, K.…

Read More

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

Podrazil M, Horvath R, Becht E, et al. Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. (2015). Oncotarget, 5, 17891-17904.  DOI: 10.18632/oncotarget.4145

Read More
Search for:

Blog Archives

Signup Area

Sign Up for Email Updates

Biolife Logo

  • Products
  • Company
  • Evidence
  • Investors
  • Blog
  • Ask the Scientists
  • Press Releases
  • Contact
© 2019 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
  • twitter
  • linkedin
  • facebook